These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31836775)

  • 21. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.
    Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T
    Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
    Lai IR; Lee WJ; Huang MT; Lin HH
    Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer.
    Jing R; Cui M; Ju S; Pan S
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Progastrin-Releasing Peptide Expression is Associated with Progression in Gastric Cancer Patients.
    Li L; Yin X; Meng H; Hu J; Yu Z; Xu J
    Yonsei Med J; 2020 Jan; 61(1):15-19. PubMed ID: 31887795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Serum CA72-4 and CEA Levels in Patient with Endoscopically Suspected Gastric Carcinoma.
    Rehena Z; Ghosh CK; Afroz F; Alam MB; Ferdousi S; Mahmuduzzaman M; Sultana T; Ahmed AN
    Mymensingh Med J; 2015 Jul; 24(3):542-9. PubMed ID: 26329953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
    Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A
    Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer.
    Li Y; Yang Y; Lu M; Shen L
    Hepatogastroenterology; 2011; 58(112):2166-70. PubMed ID: 22024091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical application of thioredoxin reductase as a novel biomarker in liver cancer.
    Wu X; Wang Q; Lu Y; Zhang J; Yin H; Yi Y
    Sci Rep; 2021 Mar; 11(1):6069. PubMed ID: 33727662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer].
    Zhu YB; Ge SH; Zhang LH; Wang XH; Xing XF; DU H; Hu Y; Li YA; Jia YN; Lin Y; Fan B; Ji JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):161-4. PubMed ID: 22368025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of Plasma-Methylated
    Miao J; Liu Y; Zhao G; Liu X; Ma Y; Li H; Li S; Zhu Y; Xiong S; Zheng M; Fei S
    Cancer Control; 2020; 27(2):1073274820922559. PubMed ID: 32379490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection.
    Liu X; Qiu H; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z; Sun X
    Oncotarget; 2016 Jun; 7(23):35446-53. PubMed ID: 27147574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioredoxin reductase as a novel biomarker for the diagnosis and efficacy prediction of gastrointestinal malignancy: a large-scale, retrospective study.
    Hu Y; Zhu Y; Nie W; Shi J; Wei X; Tang C; Zhang W
    Int J Clin Oncol; 2023 Jul; 28(7):880-892. PubMed ID: 37142881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies.
    Kornek GV; Depisch D; Rosen HR; Temsch EM; Scheithauer W
    J Cancer Res Clin Oncol; 1992; 118(4):318-20. PubMed ID: 1374412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
    Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
    Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer.
    Zhu Y; Hu Y; Shi J; Wei X; Song Y; Tang C; Zhang W
    Technol Cancer Res Treat; 2023; 22():15330338231184995. PubMed ID: 37365925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.
    Wu J; Li G; Yao Y; Wang Z; Sun W; Wang J
    Biomarkers; 2015 Feb; 20(1):58-63. PubMed ID: 25510566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative Tumor Markers Independently Predict Survival in Stage III Gastric Cancer Patients: Should We Include Tumor Markers in AJCC Staging?
    Lin JX; Wang W; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Zhou ZW; Li P
    Ann Surg Oncol; 2018 Sep; 25(9):2703-2712. PubMed ID: 29971670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer.
    Tian SB; Yu JC; Kang WM; Ma ZQ; Ye X; Cao ZJ; Yan C
    Asian Pac J Cancer Prev; 2014; 15(15):6295-300. PubMed ID: 25124614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.